TO TARGET STUDY: INTERIM ANALYSIS OF A SINGLE-ARM STUDY TO ASSESS ACHIEVEMENT OF NKF-K/DOQI MINERAL METABOLISM TARGETS IN AUSTRALIAN DIALYSIS PATIENTS USING SENSIPAR®

被引：0
作者：
Masterson, R. [1 ]
Talaulikar, G. [2 ]
Mantha, M.
Jones, B. [3 ]
Bannister, K. [4 ]
Tolman, C.
Manamley, N.
机构：
[1] Royal Melbourne Hosp, Melbourne, Vic, Australia
[2] Canberra Hosp, Canberra, ACT, Australia
[3] John Hunter Hosp, Sydney, NSW, Australia
[4] Royal Adelaide Hosp, Adelaide, SA, Australia
来源：
NEPHROLOGY | 2008年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
184
引用
收藏
页码：A148 / A148
页数：1
相关论文
共 37 条
[31]   A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis [J].
Polak, Pavol ;
Peric, Porin ;
Louw, Ingrid ;
Gaylord, Stefanie M. ;
Williams, Theresa ;
Becker, Jean-Claude ;
Pedersen, Ron ;
Korth-Bradley, Joan ;
Vlahos, Bonnie .
EUROPEAN JOURNAL OF RHEUMATOLOGY, 2019, 6 (01) :23-+
[32]   SAFETY AND PRELIMINARY ACTIVITY OF PT2385, A FIRST-IN-CLASS HIF2-ALPHA INHIBITOR, PLANNED INTERIM ANALYSIS OF AN OPEN LABEL, SINGLE-ARM PHASE II STUDY IN PATIENTS WITH RECURRENT GLIOBLASTOMA [J].
Strowd, Roy ;
Ellingson, Benjamin ;
Wen, Patrick ;
Ahluwalia, Manmeet ;
Piotrowski, Anna ;
Desai, Arati ;
Clarke, Jennifer ;
Lieberman, Frank ;
Desideri, Serena ;
Nabors, L. Burt ;
Grossman, Stuart .
NEURO-ONCOLOGY, 2018, 20 :14-14
[33]   Planned Interim Analysis Results from a Prospective Multicenter Single-Arm Cohort Study of Patients Receiving Endocrine Therapy but Not Radiotherapy after Breast-Conserving Surgery for Early-Stage Breast Cancer with Favorable Biologic Features [J].
Jagsi, R. ;
Griffith, K. ;
Harris, E. E. ;
Wright, J. L. ;
Recht, A. ;
Taghian, A. G. ;
Lee, L. ;
Moran, M. S. ;
Thomas, T. O., Jr. ;
Johnstone, C. ;
Rahimi, A. S. ;
Freedman, G. M. ;
Muzaffar, M. ;
Haffty, B. G., Jr. ;
Horst, K. C. ;
Powell, S. N. ;
Sharp, J. ;
Sabel, M. S. ;
Schott, A. F. ;
El-Tamer, M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01) :S7-S8
[34]   Clinical Effectiveness and Impact on Patient-Reported Outcomes of Delayed-Release Dimethyl Fumarate in Relapsing Multiple Sclerosis Patients after Suboptimal Response to Glatiramer Acetate: Six-Month Interim Analysis of a Prospective, Multicenter, Open-Label, Single-Arm, Observational Study (RESPOND) [J].
Kresa-Reahl, Kiren ;
Repovic, Pavle ;
Robertson, Derrick ;
Okwuokenye, Macaulay ;
Meltzer, Leslie ;
Mann, Monica .
NEUROLOGY, 2016, 86
[35]   Clinical Effectiveness and Impact on Patient-Reported Outcomes of Delayed-Release Dimethyl Fumarate in Relapsing Multiple Sclerosis Patients after Suboptimal Response to Glatiramer Acetate: Six-Month Interim Analysis of a Prospective, Multicenter, Open-Label, Single-Arm, Observational Study (RESPOND) [J].
Kresa-Reahl, Kiren ;
Repovic, Pavle ;
Robertson, Derrick ;
Okwuokenye, Macaulay ;
Meltzer, Leslie ;
Mann, Monica .
NEUROLOGY, 2016, 86
[36]   Planned interim analysis of PATRICIA: An open-label, single-arm, phase II study of pertuzumab (P) with high-dose trastuzumab (H) for the treatment of central nervous system (CNS) progression post radiotherapy (RI) in patients (pts) with HER2-positive metastatic breast cancer (MBC). [J].
Lin, Nancy U. ;
Stein, Alisha ;
Nicholas, Alan ;
Fung, Anita M. ;
Kumthekar, Priya ;
Ibrahim, Nuhad K. ;
Pegram, Mark D. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[37]   Osimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS study [J].
Zhou, Q. ;
Zhang, H. ;
Jiang, L. ;
Shi, Y. ;
Chen, Y. ;
Yu, J. ;
Zhou, C. ;
He, Y. ;
Hu, Y. ;
Liang, Z-A. ;
Pan, Y. ;
Zhuo, W. ;
Song, Y. ;
Wu, G. ;
Chen, G. ;
Lu, Y. ;
Cheng, Y. ;
Lu, S. ;
Wang, J. ;
Wu, Y. L. .
ANNALS OF ONCOLOGY, 2018, 29 :158-158
1234